甲硝唑 → Metronidazole Carbonate

HRID 533286笔记

反应方程式

HRID 533286 反应方程式
ClC(Cl)([O:4][C:5](=[O:11])[O:6]C(Cl)(Cl)Cl)Cl.[CH3:13][C:14]1[N:18]([CH2:19][CH2:20][OH:21])[C:17]([N+:22]([O-:24])=[O:23])=[CH:16][N:15]=1>CN(C1C=CN=CC=1)C.C(Cl)Cl>[CH3:13][C:14]1[N:18]([CH2:19][CH2:20][OH:21])[C:17]([N+:22]([O-:24])=[O:23])=[CH:16][N:15]=1.[C:5](=[O:4])([O-:11])[O-:6]

参与物

5

反应物 2

HCID 4173甲硝唑HCID 94429三光气

产物 1

HCID 68777643Metronidazole Carbonate收率 279.9%

试剂、催化剂与溶剂 2

HCID 142844-二甲氨基吡啶(DMAP)催化剂HCID 6344二氯甲烷溶剂

实验过程

mPEG3OH (1.0 mmol, 164 mg) and DMAP [4-(dimethylamino)pyridine, 2.4 mmol] were dissolved in anhydrous DCM (dichloromethane, 20 ml). Triphosgene (0.34 mmol, 99 mg) was added at room temperature. The solution was stirred at room temperature for 15 minutes. Metronidazole (1.0 mmol, 171 mg) was added and the reaction solution was stirred at room temperature for two hours. The solvent was evaporated at reduced pressure. The residue was subjected to flash chromatography (methanol/DCM=2˜5%) to obtain compound 2a (220 mg, yield 61%). 1H NMR (CDCl3) δ 7.99 (s, 1H), 4.61 (t, 2H), 4.50 (t, 2H), 4.28 (t, 2H), 3.73-3.40 (m, 10H), 3.40 (s, 3H), 2.53 (s, 3H). LC/MS 362 [M+H]+.

后处理

  1. stirringthe reaction solution was stirred at room temperature for two hours
  2. customThe solvent was evaporated at reduced pressure

来源与证据

ORD记录
ord-4483eec2b0eb4e9dad50219571c6765c
来源数据集
uspto-grants-2014_10
专利号
US08853247B2

反应笔记

加载中…